Skip to main content

Table 5 Nano material sterilization performance

From: Biological Stability of Water-Based Cutting Fluids: Progress and Application

Material Size (nm) MIC (mg/mL) Zone of inhibition (mm) Percentage inhibition Ref. No.
AgNPS    8.1–36.4   [166]
50‒80 0.3×10−4‒0.047 S. aureus: 1.4‒2.0;
E. coli: 0.8‒1.8
  [168]
   9‒16   
  C.albicans:
MIC50=0.5,
MIC90=2;
S. cerevisiae: MIC50=4,
MIC90=32
   [163]
10-25 5.8×10-3    [167]
n-Ag3O4 18   S. aureus: 13‒16;
P. Aeruginosa: 13‒16
  [169]
f- Ag3O4 30   S. aureus: 7‒8;
P. Aeruginosa: 7‒11
 
n-NiO 16   S. aureus: 5‒6;
P. Aeruginosa: 6‒7
  [158]
f-NiO 20   S. aureus: 7‒15;
P. Aeruginosa: 12‒17
 
Cu2O   MIC50=0.01
MIC90=0.055
   [176]
SiO2 50‒100 B. subtilis: 6%‒2%;
E. coli: 4.5%‒1%
   [171]
SiO2+Ag 16‒35 B. subtilis: 0.016‒0.500;
E. coli: 0.008‒0.25
   [170]
GO     S. aureus: 97.3%
P. Aeruginosa: 48.6%
[42]
rGO     S. aureus: 67.7%
P. Aeruginosa: 93.3%
  1. Note: Staphylococcus aureus: S. aureus; Pseudomonas aeruginosa: P. Aeruginosa; Escherichia coli: E. coli; Bacillus subtilis: B. subtilis; candida albicans: C.albicans; Saccharomyces cerevisiae: S. cerevisiae; non-functionalized silver oxide nanoparticles referred as n-Ag3O4, functionalized nanoparticles as f-Ag3O4; non-functionalized nickel oxide nano-particles are referred to as n-NiO, functionalized nickel oxide nanoparticles as f-NiO; graphene oxide: GO; reduced GO: rGO